Literature DB >> 10072528

IL-5 induces IgG1 isotype switch recombination in mouse CD38-activated sIgD-positive B lymphocytes.

C Mizoguchi1, S Uehara, S Akira, K Takatsu.   

Abstract

Mouse B cells express CD38, whose ligation by anti-CD38 Ab induces their proliferation and protection from apoptosis. We previously showed that stimulation of mouse splenic B cells with IL-5 together with CS/2, an anti-mouse CD38 mAb, induces production of IgG1 and IgM. Here we examined the role of IL-5 and CS/2 in the expression of germline gamma1 transcripts and the generation of reciprocal products forming DNA circles as byproducts of mu-gamma1 switch recombination. By itself, CS/2 induced significant expression of germline gamma1 transcripts in splenic naive B cells, whereas IL-5 neither induced nor enhanced germline gamma1 expression. Increased cellular content of reciprocal product, which is characteristic of mu-gamma1 recombination, was not observed after culturing B cells with CS/2, but increased reciprocal product, along with high levels of lgG1 secretion, was found when B cells were cultured with CS/2 plus IL-5. Although IL-4 did not, by itself, induce mu-gamma1 recombination in B cells stimulated with CS/2, in conjunction with CS/2 plus IL-5, IL-4 dramatically enhanced sterile gamma1 transcription and IgG1 production. These results demonstrate that CD38 ligation induces only germline gamma1 transcription and that IL-5 promotes both mu-gamma1 switch recombination and lgG1 secretion in an IL-4-independent manner.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10072528

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

1.  Presentation of high antigen-dose by splenic B220(lo) B cells fosters a feedback loop between T helper type 2 memory and antibody isotype switching.

Authors:  Jason S Ellis; F Betul Guloglu; Habib Zaghouani
Journal:  Immunology       Date:  2016-01-28       Impact factor: 7.397

2.  Soluble CD38 significantly prolongs the lifespan of memory B-cell responses.

Authors:  Xue Q Liu; Derek N J Hart; Gordon G MacPherson; Michael F Good; Michelle N Wykes
Journal:  Immunology       Date:  2008-09       Impact factor: 7.397

3.  Interleukin-5 regulates genes involved in B-cell terminal maturation.

Authors:  Keisuke Horikawa; Kiyoshi Takatsu
Journal:  Immunology       Date:  2006-08       Impact factor: 7.397

4.  Functional dissection of the cytoplasmic subregions of the interleukin-5 receptor alpha chain in growth and immunoglobulin G1 switch recombination of B cells.

Authors:  B G Moon; T Yoshida; M Shiiba; K Nakao; M Katsuki; S Takaki; K Takatsu
Journal:  Immunology       Date:  2001-03       Impact factor: 7.397

5.  A role for interleukin-5 in promoting increased immunoglobulin M at the site of disease in leprosy.

Authors:  Maria T Ochoa; Rosane Teles; Blake E Haas; Danny Zaghi; Huiying Li; Euzenir N Sarno; Thomas H Rea; Robert L Modlin; Delphine J Lee
Journal:  Immunology       Date:  2010-11       Impact factor: 7.397

6.  Dendritic cells and follicular dendritic cells express a novel ligand for CD38 which influences their maturation and antibody responses.

Authors:  Michelle N Wykes; Lynette Beattie; Gordon G Macpherson; Derek N Hart
Journal:  Immunology       Date:  2004-11       Impact factor: 7.397

7.  Deficiency of mannose-binding lectin greatly increases antibody response in a mouse model of vaccination.

Authors:  Hilde-Kari Guttormsen; Lynda M Stuart; Lei Shi; Mike C Carroll; Jianzhu Chen; Dennis L Kasper; R Alan B Ezekowitz; Kazue Takahashi
Journal:  Clin Immunol       Date:  2008-11-08       Impact factor: 3.969

8.  Increased numbers of CD38 molecules on bright CD8+ T lymphocytes in infectious mononucleosis caused by Epstein-Barr virus infection.

Authors:  S Zidovec Lepej; A Vince; O Dakovic Rode; A Remenar; T Jeren
Journal:  Clin Exp Immunol       Date:  2003-09       Impact factor: 4.330

9.  Immunity in HIV-1-infected adults with a previous state of moderate-severe immune-suppression and more than 500 CD4+ T cell after highly active antiretroviral therapy.

Authors:  Salvador Resino; Laura Rivero; Ezequiel Ruiz-Mateos; Isabel Galán; Jaime Munoz Franco; Maria Angeles Munoz-Fernández; Manuel Leal
Journal:  J Clin Immunol       Date:  2004-07       Impact factor: 8.317

Review 10.  Interleukin-5 and IL-5 receptor in health and diseases.

Authors:  Kiyoshi Takatsu
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2011       Impact factor: 3.493

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.